Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Sironi

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Journal of Hypertension|May 11, 2012
'Les liaisons dangereuses': the inextricable link between blood pressure and kidney. The hypertensive rat strains as a possibility to untangle itLuigi Sironi, Paolo Gelosa
The Annals of Thoracic Surgery|September 27, 2005
Invited commentaryGiulio Pompilio, Luigi Sironi
Biochemical Pharmacology|March 8, 2020
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?Paolo Gelosa, Laura Castiglioni, Marina Camera, et al.
Journal of Voice : Official Journal of the Voice Foundation|August 10, 2020
Neural Correlates of Esophageal Speech: An fMRI Pilot StudyLucilla Guidotti, Davide Negroni, Luigi Sironi, et al.
Journal of Hypertension|November 15, 2008
The hard way to acute stroke treatmentLuigi Sironi, Paolo Gelosa, Elena Tremoli, et al.
Biochemical Pharmacology|March 7, 2020
Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?Paolo Gelosa, Laura Castiglioni, Marina Camera, et al.
BMJ Case Reports|May 7, 2014
Neurophysiological findings in a newborn with chromosome 10 trisomySimone Vidale, Franco Di Palma, Luigi Sironi, et al.
Drugs of Today (Barcelona, Spain : 1998)|December 13, 2005
Anti-inflammatory properties of drugs acting on the renin-angiotensin systemLuigi Sironi, Elena Nobili, Anita Gianella, et al.
Mediators of Inflammation|September 22, 2017
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular DiseasesFrancesca Colazzo, Paolo Gelosa, Elena Tremoli, et al.
Mediators of Inflammation|June 14, 2017
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral DiseasesPaolo Gelosa, Francesca Colazzo, Elena Tremoli, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Journal of Hypertension|May 11, 2012
'Les liaisons dangereuses': the inextricable link between blood pressure and kidney. The hypertensive rat strains as a possibility to untangle itLuigi Sironi, Paolo Gelosa
The Annals of Thoracic Surgery|September 27, 2005
Invited commentaryGiulio Pompilio, Luigi Sironi
Biochemical Pharmacology|March 8, 2020
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?Paolo Gelosa, Laura Castiglioni, Marina Camera, et al.
Journal of Voice : Official Journal of the Voice Foundation|August 10, 2020
Neural Correlates of Esophageal Speech: An fMRI Pilot StudyLucilla Guidotti, Davide Negroni, Luigi Sironi, et al.
Journal of Hypertension|November 15, 2008
The hard way to acute stroke treatmentLuigi Sironi, Paolo Gelosa, Elena Tremoli, et al.
Biochemical Pharmacology|March 7, 2020
Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?Paolo Gelosa, Laura Castiglioni, Marina Camera, et al.
BMJ Case Reports|May 7, 2014
Neurophysiological findings in a newborn with chromosome 10 trisomySimone Vidale, Franco Di Palma, Luigi Sironi, et al.
Drugs of Today (Barcelona, Spain : 1998)|December 13, 2005
Anti-inflammatory properties of drugs acting on the renin-angiotensin systemLuigi Sironi, Elena Nobili, Anita Gianella, et al.
Mediators of Inflammation|September 22, 2017
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular DiseasesFrancesca Colazzo, Paolo Gelosa, Elena Tremoli, et al.
Mediators of Inflammation|June 14, 2017
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral DiseasesPaolo Gelosa, Francesca Colazzo, Elena Tremoli, et al.
Pageof 9